Under its agreement with states, the the Centers for Disease Control and Prevention (CDC) is barred from publicly identifying hospitals that are battling to contain the spread of dangerous pathogens, according to an article on The New York Times website.
The rise of a deadly drug-resistant fungus called Candida auris has raised questions about the policy of secrecy.
Patient advocates say the lack of transparency can potentially endanger patients.
“They might not get up and go to another hospital, but patients and their families have the right to know when they are at a hospital where an outbreak is occurring,” Lisa McGiffert of the Patient Safety Action Network, said in the article. “That said, if you’re going to have hip replacement surgery, you may choose to go elsewhere.”
Charging Ahead: Incentives Driving EV Charging in Healthcare Facilities
Outpatient Growth and the Future of Healthcare Real Estate
Mount Sinai South Nassau Opens Expanded Emergency Department
Lehigh Valley Health Network to Open Fourth Neighborhood Hospital in 2026
Creating an Emergency Preparedness Plan with NFPA 99